--- title: "enCore Energy (CVE:EU) Shares Up 3.9% - What's Next?" type: "News" locale: "en" url: "https://longbridge.com/en/news/282761219.md" description: "enCore Energy Corp. (CVE:EU) shares rose 3.9% to C$2.68 on Tuesday, with 506,743 shares traded, down 11% from the average volume. Northland Securities upgraded the stock to a \"strong-buy\" rating, contributing to its overall \"Strong Buy\" consensus among analysts. The company, focused on uranium resource properties in the U.S., has a market cap of C$520.50 million and a P/E ratio of -8.93. Despite the positive outlook, it was noted that enCore Energy is not among the top five stocks recommended by analysts at this time." datetime: "2026-04-15T00:54:04.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/282761219.md) - [en](https://longbridge.com/en/news/282761219.md) - [zh-HK](https://longbridge.com/zh-HK/news/282761219.md) --- # enCore Energy (CVE:EU) Shares Up 3.9% - What's Next? enCore Energy Corp. (CVE:EU - Get Free Report)'s share price was up 3.9% on Tuesday . The company traded as high as C$2.72 and last traded at C$2.68. Approximately 506,743 shares changed hands during trading, a decline of 11% from the average daily volume of 566,317 shares. The stock had previously closed at C$2.58. Get **enCore Energy** alerts: ## Wall Street Analysts Forecast Growth Separately, Northland Securities raised shares of enCore Energy to a "strong-buy" rating in a research note on Tuesday, January 6th. Two investment analysts have rated the stock with a Strong Buy rating, According to data from MarketBeat.com, the company currently has an average rating of "Strong Buy". **Get Our Latest Stock Report on EU** ## enCore Energy Stock Performance The stock has a 50 day moving average of C$3.00 and a two-hundred day moving average of C$3.67. The firm has a market capitalization of C$520.50 million, a P/E ratio of -8.93 and a beta of 1.46. ## About enCore Energy (Get Free Report) enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. It holds a 100% interest in the Crownpoint and Hosta Butte uranium project that covers 3,020 acres located in the Grants Uranium Belt, New Mexico. The company also has interests in the Marquez-Juan Tafoya property, which consists of 14,582 acres located in McKinley and Sandoval counties of New Mexico; and the Nose Rock project that covers 42 owned unpatented lode mining claims comprising approximately 800 acres located in McKinley County, New Mexico. ## Featured Stories - Five stocks we like better than enCore Energy _This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._ ## Should You Invest $1,000 in enCore Energy Right Now? Before you consider enCore Energy, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and enCore Energy wasn't on the list. While enCore Energy currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [EU.US](https://longbridge.com/en/quote/EU.US.md) ## Related News & Research - [enCore Energy (CVE:EU) Trading Up 2.4% - Should You Buy?](https://longbridge.com/en/news/269485422.md) - [Citi Just Set a Fresh Street-High Target of $287 on Nebius Stock. Here’s Why Analysts Are Bullish.](https://longbridge.com/en/news/286818019.md) - [Is Affirm stock an undervalued stock to buy?](https://longbridge.com/en/news/286826167.md) - [Brett Heath Purchases 5,000 Shares of Metalla Royalty & Streaming (CVE:MTA) Stock](https://longbridge.com/en/news/287050872.md) - [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)